Research Papers:

Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group

Hyeyoon Chang, Woon Yong Jung, Youngran Kang, Hyunjoo Lee, Aeree Kim, Han Kyeom Kim, Bong Kyung Shin and Baek-hui Kim _

PDF  |  HTML  |  How to cite

Oncotarget. 2016; 7:80426-80434. https://doi.org/10.18632/oncotarget.12603

Metrics: PDF 1808 views  |   HTML 2517 views  |   ?  


Hyeyoon Chang1, Woon Yong Jung2, Youngran Kang3, Hyunjoo Lee4, Aeree Kim1, Han Kyeom Kim1, Bong Kyung Shin1, Baek-hui Kim1

1Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Guro-gu, Seoul, Republic of Korea

2Department of Pathology, Catholic Kwandong University International St Mary’s Hospital, Incheon, Republic of Korea

3Department of Pathology, Green Cross Laboratories, Yongin, Kyeonggi-Do, Republic of Korea

4Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine, Seoul, Republic of Korea

Correspondence to:

Baek-hui Kim, email: [email protected]

Keywords: gastric adenocarcinoma, PD-1, PD-L1, CTLA-4, prognosis

Received: May 20, 2016     Accepted: October 02, 2016     Published: October 12, 2016


Gastric adenocarcinoma is one of the most common causes of cancer-related death. In this study, we conducted immunohistochemical studies for PD-L1, PD-1, CTLA-4, and CD8 using tissue microarrays from 464 gastric cancer samples and evaluated the correlations between their expression, clinicopathologic factors, and five-year overall survival. PD-L1 and PD-1 expression was significantly correlated with several adverse prognostic pathologic factors, including higher T-stage, diffuse Lauren histologic type, and lymphatic invasion. Conversely, CTLA-4 expression was correlated with factors of favorable clinical outcomes. A complete case analysis revealed that high PD-L1 and PD-1 expression had an adverse effect on five-year overall survival in univariate analyses. Subgroup analyses wherein patients were divided into two groups according to CD8+ tumor infiltrating lymphocyte levels (high and low) showed that high PD-L1 expression was a significant adverse prognostic factor only in the high CD8+ tumor-infiltrating lymphocytes group. Further research and clinical trials are needed to determine the clinical usefulness of these findings.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 12603